Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

Thesis (Ph.D.)--Hong Kong University of Science and Technology, 2008. / Includes bibliographical references. Also available in electronic version.

Thesis (M.S.)--Brigham Young University. Dept. of Chemistry and Biochemistry, 2007. / Includes bibliographical references (p. 117-122).

This investigation deals with the synthesis of 2-alkylpyridine and 2-alkylpyrazine derivatives of 2,3-dichloro-1,4-naphthoquinone. These compounds will be tested for physiological activity by Parke-Davis and Company.

In spite of great effort aimed at eradication, the malaria epidemic still claims over 600,000 lives each year, and 50% of the world is at risk of contracting the disease. The most deadly form of malaria is caused by Plasmodium falciparum, which is spread from human to human via the female Anopheles mosquito. P. falciparum's lifecycle, which includes both sexual and asexual reproduction, facilitates rapid evolution in response to drug pressure, resulting in the emergence of resistant strains against every antimalarial medication that has been deployed. There is a great need for new antimalarial drugs. Chloroquine (CQ), an aminoquinoline drug deployed in the 1940s, was an inexpensive, effective and safe drug but now has been rendered ineffective throughout much of the tropical regions due to the emergence of CQ-resistant strains of P. falciparum. A new class of hybrid drugs, called Reversed-CQs, has been developed by linking a molecule with a CQ-like moiety to a molecule with a reversal agent (RA) moiety; an RA is a chemosensitizer that can reverse CQ-resistance. The prototype Reversed-CQ, PL01, was shown to be effective in vitro against sensitive and resistant P. falciparum cell cultures, with IC50 values of 2.9 and 5.3 nM, respectively, in comparison to IC50 values for CQ which were 6.9 and 102 nM, respectively. In the course of the Reversed-CQ research, PL74 was synthesized with a pyridine ring replacing the quinoline ring. It was expected that PL74 would display reversal agent activity but would not display antimalarial activity. However PL74 showed antimalarialactivity with IC50 values of 185 and 169 nM in vitro against CQ-sensitive and CQ-resistant strains, respectively. In the investigation of PL74 it has been found that this molecule has a pyridinium salt structure, novel to the Reversed-CQ compounds, and through a structure-activity relationship (SAR) study, it was shown to have activity that may indicate a mode of action different from the Reversed-CQ compounds. A study of the literature revealed that pyridinium salt compounds, with some similarity to PL74, were found to operate as choline analogs inhibiting the biosynthesis of phosphatidylcholine as their main antimalarial mode of action.

It has been observed by Kröhnke, that certain N-substituted pyridinum compunds possess both pressor and ergot-like activity. It has also been reported that both N-phenacylpiperidinium hydrochloride and the corresponding carbinol have some value as local anaesthetics.

No description available.

Notre stratégie de stockage d’électrons repose sur la formation et la rupture de liaisons chimiques fonctionnant comme des réservoirs d’électrons. Le processus de formation réversible de liaisons est rendu possible grâce à la pré-organisation de groupements électroactifs – des pyridiniums – autour de plateformes aromatiques rigides et semi-rigides. Le relargage des électrons stockés au sein des réservoirs d’électrons par rupture de liaison suggère de manipuler des liaisons de nature affaiblie, c’est-à-dire allongées et contraintes stériquement, comme celles résultantes d’interactions hors-du-plan des groupements électrophoriques. Les contraintes stériques permettent ainsi la formation et la rupture de ces liaisons dans une gamme d’énergie raisonnable. Les pyridiniums sont des unités électrophoriques de choix dû à la versatilité de leurs propriétés de réduction. Les assemblages obtenus sont des systèmes bistables qui montrent des propriétés électrochimiques hystérétiques remarquables. En général, ce comportement repose sur la proche proximité des groupements électrophoriques qui permettent la formation d’une (ou plusieurs) orbitale(s) supramoléculaire(s) vacante(s) et liante(s) (SupLUMOs). Lors de la réduction, cette orbitale accueille deux électrons créant ainsi la liaison d’intérêt. Une famille de composés modèles a ainsi été conçue et synthétisée impliquant la formation réversible de liaisons homonucléaires (Csp3‒Csp3). Ces liaisons sont de nature localisée dans des systèmes à deux pyridiniums (bi-électroniques) et délocalisée dans des systèmes de plus de deux pyridiniums. / Our strategy to store electrons is based on chemical bond formation/cleavage being used as electron reservoirs. Reversible bond formation results from the preorganization of electrophoric moieties – pyridiniums – around aromatic rigid and semi-rigid scaffold. Using lower energy bonds is required to release stored electrons from the reservoirs. Such bonds can be obtained from sterically hindered out-of-plan bond formation between two electrophorical subunits. The resulting elongated bond can be cleaved in an available level of energy. Pyridiniums are prime candidates to achieve such properties based on their noteworthy redox behavior. The resulting molecular devices are bistable systems that display remarkable hysteretic electrochemical properties, based on close proximity of electrophoric subunits allowing one (or more) unoccupied supramolecular bonding orbital(s) (SupLUMOs). Upon reduction, two electrons are injected in this orbital resulting in the bond of interest. An entire family of compounds has been designed and synthesized to highlight reversible homonuclear bond formation (Csp3‒Csp3). Those bonds are localized in the case of a two-pyridiniums system, and delocalized when more pyridiniums are involved.

No description available.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.